Shigenobu Kanba

Prof. Shigenobu Kanba


Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2013 in Frontiers in Behavioral Neuroscience
Verified
Journal Article
Open access
YKYuki Kobayashi
Yuki Kobayashi
YSYoshitake Sano
Yoshitake Sano
EVElisabetta Vannoni
Elisabetta Vannoni
HGHiromichi Goto
Hiromichi Goto
HSHitomi Suzuki
Hitomi Suzuki
SIShigeyoshi Itohara
Shigeyoshi Itohara
The habenular complex linking forebrain and midbrain structures is subdivided into the medial (mHb) and the lateral nuclei (lHb). The mHb is characterized by the expression of specific nicotinic acetylcholine receptor isoforms and the release of acetylcholine to the interpeduncular nucleus (IPN), the sole output region of the mHb. The specific function of this circuit, however, is poorly understood. Here we generated transgenic mice in which mHb cells were selectively ablated postnatally. These lesions led to large reductions in acetylcholine levels within the IPN. The mutant mice exhibited abnormalities in a wide range of behavioral domains. They tended to be hyperactive during the early night period and were maladapted when repeatedly exposed to new environments. Mutant mice also showed a high rate of premature responses in the 5-choice serial reaction time task (5-CSRTT), indicating impulsive and compulsive behavior. Additionally, mice also exhibited delay and effort aversion in a decision-making test, deficits in spatial memory, a subtle increase in anxiety levels, and attenuated sensorimotor gating. IntelliCage studies under social housing conditions confirmed hyperactivity, environmental maladaptation, and impulsive/compulsive behavior, delay discounting, deficits in long-term spatial memory, and reduced flexibility in complex learning paradigms. In 5-CSRTT and adaptation tasks, systemic administration of nicotine slowed down nose-poke reaction and enhanced adaptation in control but not mutant mice. These findings demonstrate that the mHb–IPN pathway plays a crucial role in inhibitory control and cognition-dependent executive functions.

5 July 2012 in PLOS ONE
Verified
Journal Article
Open access
PDF file
YOYuko Oda
Yuko Oda
TOToshiaki Onitsuka
Toshiaki Onitsuka
RTRikako Tsuchimoto
Rikako Tsuchimoto
SHShogo Hirano
Shogo Hirano
NONaoya Oribe
Naoya Oribe
SKShigenobu Kanba
Shigenobu Kanba
Periodic auditory click stimulation has been reported to elicit an auditory steady state response (ASSR). The ASSR has been suggested to reflect the efficiency of γ-amino butyric acid (GABA) inhibitory interneuronal activity. Although a potential role for GABAergic dysfunction has been previously proposed, the role of neural synchronization in the ASSR in people with bipolar disorder (BD) has received little attention. In the current study, we investigated ASSRs to 20 Hz, 30 Hz, 40 Hz and 80 Hz click trains in BD patients. A total of 14 (4 males) BD patients and 25 (10 males) healthy controls participated in this study. ASSRs were obtained using whole-head 306-channel magnetoencephalography to calculate, ASSR power values and phase locking factors (PLF). BD patients exhibited significantly reduced mean ASSR power and PLF values bilaterally at frequencies of 30, 40, and 80 Hz (p<0.05 for these frequencies). At 20 Hz, bipolar patients showed no significant reduction in mean ASSR power and PLF values. There was a significant negative correlation between 80 Hz-ASSR-power values obtained from the right hemisphere and scores on the Hamilton Depression Rating Scale (rho = −0.86, p = 0.0003). The current study showed reduced low and high gamma band ASSR power and PLF bilaterally with no significant beta band ASSR reduction in BD patients. BD patients are characterized by deficits in gamma band oscillations, which may be associated with GABA inhibitory interneuronal activity dysfunction.

1 August 2006 in European Archives of Psychiatry and Clinical Neuroscience
Verified
Journal Article
Closed access
PDF file
YIY. Inoue
Y. Inoue
KYK. Yamada
K. Yamada
MHM. Hirano
M. Hirano
MSM. Shinohara
M. Shinohara
TTT. Tamaoki
T. Tamaoki
SKShigenobu Kanba
Shigenobu Kanba

18 June 2013 in Psychiatry and Clinical Neurosciences
Verified
Journal Article
Closed access
PDF file
SKShigenobu Kanba
Shigenobu Kanba
TKTadafumi Kato
Tadafumi Kato
TTTakeshi Terao
Takeshi Terao
KYKazuo Yamada
Kazuo Yamada

21 December 2007 in International Journal of Neuropsychopharmacology
Verified
Journal Article
Open access
PDF file
Norman SaratoriusNorman Saratorius
Norman Saratorius
TBThomas C. Baghai
Thomas C. Baghai
DBDavid S. Baldwin
David S. Baldwin
BBBarbara Barrett
Barbara Barrett
UBUrsula Brand
Ursula Brand
ARAnita Riecher-Rössler
Anita Riecher-Rössler

18 September 2013 in BMC Public Health
Verified
Journal Article
Open access
PDF file
ASAtsuko Sekita
Atsuko Sekita
HAHisatomi Arima
Hisatomi Arima
TNToshiharu Ninomiya
Toshiharu Ninomiya
TOTomoyuki Ohara
Tomoyuki Ohara
YDYasufumi Doi
Yasufumi Doi
YKYutaka Kiyohara
Yutaka Kiyohara
Background: Uncertainty still surrounds the association between metabolic syndrome (MetS) and depression. We aimed to evaluate the association between MetS and elevated depressive symptoms in a general Japanese population.Methods: This is a cross-sectional survey of 3,113 community-dwelling individuals aged 40 years or over. MetS was defined according to the joint interim statement. MetS was diagnosed when a subject had three or more of the following components: 1) central obesity (waist circumference ≥90 cm for men, ≥80 cm in for women); 2) elevated blood pressure (≥130/85 mmHg or current use of antihypertensive medication); 3) hypertriglyceridemia (≥1.7 mmol/L); 4) low HDL cholesterol (< 1.0 mmol/L for men, < 1.3 mmol/L for women); and 5) elevated fasting plasma glucose (≥5.55 mmol/L or current use of antidiabetic medication). Depressive symptoms were assessed using the Center for Epidemiologic Studies Depression Scale (CES-D). The age- and multivariable-adjusted odds ratio (OR) and 95% confidence interval (CI) were estimated using a logistic regression model.Results: Elevated depressive symptoms were observed in 4.3% of male and 6.3% of female participants. In men, the age-adjusted prevalence of elevated depressive symptoms was significantly higher in subjects with MetS than in those without (7.1% versus 3.6%, p = 0.04). The prevalence of elevated depressive symptoms rose progressively as the number of MetS components increased (3.5%, 3.6%, 5.8%, and 9.2% in male subjects with 0–1, 2, 3, and ≥4 components, respectively; p = 0.02 for trend). This association remained significant even after adjustment for age, marital status, history of cardiovascular disease, smoking habit, alcohol intake, and regular exercise. In women, on the other hand, there was no clear association between MetS and depressive symptoms.Conclusions: MetS was associated with elevated depressive symptoms in a general population of Japanese men.